QSAR and docking studies on the pyrimidine derivatives analogs with antileishmanial activity

A. Ousaa, B. Elidrissi, M. Ghamali, S. Chtita, A. Aouidate, A. Ghaleb, M. Bouachrine, T. Lakhlifi

Abstract


Leishmaniasis is a disease caused by a number of species of protozoan parasites belonging to the genus Leishmania, is recognized as an important public health problem throughout the world. In a search of newer and potent antileishmanial drug, a series of 30 pyrimidine derivatives analogs were subjected to a quantitative structure activity relationship (QSAR) analysis, for studying, interpreting, and predicting activities and designing new compounds by using several statistical tools, such as principal components analysis (PCA), multiple linear regression (MLR) and non-linear regression (RNLM). The statistical results of the MLR and MNLR indicate that the determination coefficients R2 were 0.824 and 0.870, respectively. Internal and external validations were used to determine the statistical quality and predictive power of QSAR of the two MLR and MNLR models. The applicability domains of MLR and MNLR models were investigated using William’s plot to detect outliers and outsides compounds. Also the most active compounds were docked into the active site of the protein (PDB entry code: 2JK6) to confrm those obtained results from QSAR models and identify the binding interactions responsible for antileishmanial activity of those analogs.

Keywords


Leishmaniasis ; Pyrimidine derivatives ; QSAR model ; MLR ; MNLR ; Molecular modeling

Full Text:

PDF

Refbacks

  • There are currently no refbacks.




Online ISSN: 2605-6895

Authors attest that their work is original and unpublished, and is not under consideration for publication elsewhere. In addition, authors confirm that their paper has not been copied or plagiarized, in whole or in part, from other works.